Senzime AB (publ)
OTC: SNZZF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Philip Siberg
- Employees
- 54
- Headquarters
- Uppsala, Sweden
- IPO year
- 2017
- Market cap
- $75.2M
- Website
- https://senzime.com
Loading SNZZF…
Loading profile data…Frequently asked questions about SNZZF
What does Senzime AB (publ) (SNZZF) do?
Based in Uppsala, Sweden, Senzime AB (publ) is a medical technology company founded in 1999, specializing in the development and commercialization of advanced patient monitoring systems. These systems are designed to oversee individuals under anesthesia across a wide geographic reach, including Europe, Oceania, Asia, Canada, and the United State...
Where does SNZZF trade?
Senzime AB (publ) (SNZZF) trades on the Other OTC.
What sector is SNZZF in?
Senzime AB (publ) (SNZZF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Senzime AB (publ)?
Philip Siberg is the chief executive officer of Senzime AB (publ) (SNZZF).
Where is Senzime AB (publ) headquartered?
Senzime AB (publ) is headquartered in Sweden.
Does SNZZF pay a dividend?
Senzime AB (publ) (SNZZF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SNZZF go public?
Senzime AB (publ) (SNZZF) completed its initial public offering in 2017.